Back to top

TD Cowen Keeps Their Hold Rating on GlaxoSmithKline (GSK)

In a report released today, Steve Scala from TD Cowen maintained a Hold rating on GlaxoSmithKline, with a price target of $70.00. According to TipR...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GSK PLC Sponsored ADR (GSK)